Transcriptional regulation of gene expression by nuclear receptors req
uires negatively and positively acting cofactors. Recent models for re
ceptor activation propose that certain receptors in the absence of lig
ands can recruit corepressors while ligand binding results in conforma
tional changes leading to the recruitment of coactivators. Previous wo
rk has established a coactivator role for the SRC-1 Family members as
well as an involvement of the coactivators CBP/p300 in nuclear recepto
r signaling. However, in addition to coactivators, ligand-activated nu
clear receptors bind a number of different proteins that possibly serv
e other functions. Using peroxisome proliferator-activated receptor-al
pha (PPAR alpha) as bait in a yeast two-hybrid screening, we have isol
ated nuclear factor RIP140 whose function in receptor activation is un
clear. We now report a detailed characterization of RIP140 action with
a focus on the retinoid X receptor (RXR) heterodimeric receptors PPAR
and thyroid hormone receptor (TR). We show that putative PPAR ligands
enhance the interaction of RIP140 with the rat PPAR subtypes alpha an
d gamma in solution but not with PPAR/RXR heterodimers on DNA. However
, RIP140 forms ternary complexes in the presence of RXR ligands. Simil
ar experiments with Tn support the high affinity of RIP140 to the RXR
subunit and also suggest that either partner in the TR/RXR heterodimer
can independently respond to ligand. Coactivation experiments in yeas
t and mammalian cells confirm the coactivator role for SRC-1, but not
for RIP140. We provide important evidence that the in vitro binding of
RIP140 and SRC-1 to nuclear receptors is competitive. Since RIP140 ge
nerally down-regulates receptor activity in mammalian cells and specif
ically down-regulates coactivation mediated by SRC-1, we propose a mod
el in which RIP140 indirectly regulates nuclear receptor AF-2 activity
by competition for coactivators such as SRC-1.